Abacavir And Lamivudine Tablet, Film Coated
Product Images NDC 31722-838

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Abacavir And Lamivudine (NDC 31722-838). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Abacavirstructure (Abacavirstructure)

FDA Label Image
FDA Label Image

Carton (Carton)

Carton (Carton)
The text appears to be related to pharmaceutical packaging information, specifically detailing the composition and dosage instructions for film-coated tablets containing abacavir sulfate USP and lamivudine USP. It also mentions the lot number, manufacturing details, and storage instructions for the tablets. The text includes a warning to authorized dispensers and contact information for further inquiries.*
FDA Label Image

Cartonlabel (Cartonlabel)

Cartonlabel (Cartonlabel)
This text appears to be a detailed description of a medication called "Camber" - a combination of Abacavir and Lamivudine in tablet form with dosing instructions and storage guidelines. It specifies the contents of each tablet and provides a contact number for inquiries. The medication is manufactured for Camber Pharmaceuticals by Hetero Labs Limited in India.*
FDA Label Image

Lamivudinestructure (Lamivudinestructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.